Search

Your search keyword '"Biologie et Pathogénicité fongiques (BPF)"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Biologie et Pathogénicité fongiques (BPF)" Remove constraint Author: "Biologie et Pathogénicité fongiques (BPF)"
111 results on '"Biologie et Pathogénicité fongiques (BPF)"'

Search Results

1. Evaluation of the Bio-Evolution Microsporidia generic and typing real-time PCR assays for the diagnosis of intestinal microsporidiosis

2. Ethylzingerone, a Novel Compound with Antifungal Activity

3. Adenosine Triphosphate Released by Candida albicans Is Associated with Reduced Skin Infectivity

4. Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group

5. Galactomannan produced by Aspergillus fumigatus: an update on the structure, Biosynthesis and biological functions of an emblematic fungal biomarker

6. Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans

7. Candida albicans and Candida dubliniensis Show Different Trailing Effect Patterns When Exposed to Echinocandins and Azoles

8. Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling

9. The Candida albicans biofilm gene circuit modulated at the chromatin level by a recent molecular histone innovation

10. Studying fungal pathogens of humans and fungal infections: fungal diversity and diversity of approaches

11. Candida albicans : An emerging yeast model to study eukaryotic genome plasticity

12. Within-host genomic diversity of candida albicans in healthy carriers

13. Identification of recessive lethal alleles in the diploid genome of a candida albicans laboratory strain unveils a potential role of repetitive sequences in buffering their deleterious impact

14. Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort

15. Gene flow contributes to diversification of the major fungal pathogen $Candida\ albicans$

16. Candida albicans biofilms are generally devoid of persister cells

17. Systematic gene overexpression in Candida albicans identifies a regulator of early adaptation to the mammalian gut

18. Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis—The ESCAPE Study

19. Generating genomic platforms to studyCandida albicanspathogenesis

20. Evolving a pathogen to be protective The deadly fungus Candida albicans can be pushed to protect its mammalian host

21. Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms

22. A standardized toolkit for genetic engineering of CTG clade yeasts

23. A high-throughput Candida albicans two-hybrid system

24. Quelles mesures pour maîtriser le risque infectieux chez les patients immunodéprimés ? Recommandations formalisées d’experts

25. The two-component response regulator Skn7 belongs to a network of transcription factors regulating morphogenesis in Candida albicans and independently limits morphogenesis-induced ROS accumulation

26. The intraspecies diversity of C. albicans triggers qualitatively and temporally distinct host responses that determine the balance between commensalism and pathogenicity

27. Fungi as a source of food

28. Multilocus sequence typing for the analysis of clonality among Candida albicans strains from a neonatal intensive care unit

29. Administration of Zinc Chelators Improves Survival of Mice Infected with Aspergillus fumigatus both in Monotherapy and in Combination with Caspofungin

30. Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases

31. Mechanisms Underlying the Delayed Activation of the Cap1 Transcription Factor in Candida albicans following Combinatorial Oxidative and Cationic Stress Important for Phagocytic Potency

32. The Toxicity of a Novel Antifungal Compound Is Modulated by Endoplasmic Reticulum-Associated Protein Degradation (ERAD) Components

33. Candida albicans is able to use M cells as a portal of entry across the intestinal barrier in vitro

34. Analysis of repair mechanisms following an induced double-strand break uncovers recessive deleterious alleles in the candida albicans diploid genome

35. Biofilm formation in Candida glabrata: What have we learnt from functional genomics approaches?

36. Candida albicans commensalism in the gastrointestinal tract

37. Combined bacterial and fungal intestinal microbiota analyses: Impact of storage conditions and DNA extraction protocols

38. Interaction of Candida albicans Biofilms with Antifungals: Transcriptional Response and Binding of Antifungals to Beta-Glucans

39. Genetic Differences between Avian and Human Isolates of Candida dubliniensis

40. Correlation between Biofilm Formation and the Hypoxic Response in Candida parapsilosis

41. Comparative In Vitro Activities of Caspofungin and Micafungin, Determined Using the Method of the European Committee on Antimicrobial Susceptibility Testing, against Yeast Isolates Obtained in France in 2005-2006

42. Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates

43. Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88

44. Acquired Flucytosine Resistance during Combination Therapy with Caspofungin and Flucytosine for Candida glabrata Cystitis

45. Role of Cln1 during melanization of Cryptococcus neoformans

46. Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles

47. Micafungin susceptibility of the most common Candida species in 16 French university hospitals : comparison between the Etest® and the EUCAST methods (MICACAND study)

48. A FACS-optimized screen identifies regulators of genome stability in Candida albicans

49. Of mice, flies--and men? Comparing fungal infection models for large-scale screening efforts

50. Network-assisted genetic dissection of pathogenicity and drug resistance in the opportunistic human pathogenic fungus Cryptococcus neoformans

Catalog

Books, media, physical & digital resources